WHO Announces New Global Framework to Eliminate Rabies

Article

A new framework to eliminate human rabies and save tens of thousands of lives each year has been launched today by the World Health Organization (WHO), the World Organization for Animal Health (OIE), the Food and Agriculture Organization of the United Nations (FAO) and the Global Alliance for the Control of Rabies (GARC).

The framework calls for three key actions: making human vaccines and antibodies affordable, ensuring people who get bitten receive prompt treatment, and mass dog vaccinations to tackle the disease at its source.

“Rabies is 100 percent preventable through vaccination and timely immunization after exposure, but access to post-bite treatment is expensive and is not affordable in many Asian and African countries. If we follow this more comprehensive approach, we can consign rabies to the history books,” says WHO director-general Dr. Margaret Chan.

Tens of thousands of people die from rabies each year and, worldwide, 4 out of every 10 people bitten by suspected rabid dogs are children aged under 15 years. One person dies every 10 minutes, with the greatest burden in Asia and Africa.

The cost of human vaccines to protect from rabies is, however, beyond the reach of many of those who may need it. And treatment for people who are bitten can cost $40 to $50, representing an average of 40 days of wages in some of the affected countries. Recognizing that human vaccination is currently not always affordable, the new framework emphasizes prevention through vaccinating dogs – whose bites cause 99 percent of all human rabies cases. A dog vaccine costs less than $1.

“Vaccinating 70 percent of dogs regularly in zones where rabies is present can reduce human cases to zero. Eliminating canine rabies through dog vaccination is the most cost-effective and only long-term solution,” says OIE director-general Dr. Bernard Vallat. “Human deaths can be prevented when mass dog vaccination is combined with responsible pet ownership and stray dog population management, both complying with OIE intergovernmental standards, as well as with bite treatment, as recommended by WHO.”

While vaccinating dogs will be key in the new approach, the elimination of rabies – and saving the lives of those who are bitten – will not be possible without more widely-available human vaccines.

Currently, about 80 percent of people exposed to rabies live in poor, rural areas of Africa and Asia with no access to prompt treatment should they be bitten. Bringing treatment closer to victims and providing wider access to affordable vaccines and potent rabies immunoglobulins, which neutralize the rabies virus before it can get a hold in the body, are vital to achieving zero rabies deaths.

Bringing down the cost of human rabies vaccines and treatments will require strong international collaboration to make quality-assured vaccines and rabies immunoglobulin available to health centres in regions where rabies is endemic.

As of 2015, WHO and the OIE Vaccine Bank have delivered more than 15 million doses of canine rabies vaccines in many countries.

Experts, donors, and veterinary and public health officials Dec. 10-11, 2015 will adopt a plan of action that is expected to deliver prompt post-exposure prophylaxis for all in rabies endemic areas as well as a framework for scaling up sustained, large-scale dog vaccination. This milestone international conference will also discuss a push for coordinated activities targeting dog and human populations by adapting proven control strategies.

Another important component is harnessing support for community awareness and engagement to facilitate and strengthen data collection, bite incidence reporting and demand for post-exposure prophylaxis. Educating children on how to avoid being bitten is also vital.

The conference “Global elimination of dog-mediated human rabies – The time is now” is jointly organized by WHO and the OIE, in collaboration with FAO with the support of GARC.

Source: WHO

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content